SARS‐CoV‐2 and COVID‐19 for the ophthalmologist

Brandão-de-Resende, Camilo; Diniz-Filho, Alberto; Brito, Fabiano de Almeida; Vasconcelos-Santos, Daniel Vítor

doi:10.1111/ceo.13877

Cited by 9 publications

(8 citation statements)

References 121 publications

(155 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At the height of the pandemic in Australia, ophthalmology practice was extensively modified, with face‐to‐face services limited to time‐sensitive or urgent conditions. Since then, non‐urgent care has resumed, but as highlighted by the excellent review by Brandão‐de‐Resende et al, 4 practicing towards prevention of infection continues to be paramount. These measures all decrease the capacity to see patients in a clinic setting, making a return to the old normal of crowded waiting rooms unlikely in the near future.…”

mentioning

confidence: 99%

“…Coronaviruses are recognized to cause uveitis in animal models, but to date there is only one case report of bilateral anterior uveitis in a patient with COVID‐19, suggesting this is a rare complication in humans 10 . More recently, retinal complications of COVID‐19 have been described (reviewed by Brandão‐de‐Resende et al) 4 . Data on retinal changes are limited; however, there is mounting evidence of retinovascular changes in patients with COVID‐19 including retinal haemorrhages, cotton wool spots and dilatation of retinal veins.…”

mentioning

confidence: 99%

See 1 more Smart Citation

“COVID new normal” in ophthalmology: Implications for ophthalmologists, eye care, ophthalmic education and research

Mack

Fraser‐Bell

2021

Clinical Exper Ophthalmology

View full text Add to dashboard Cite

mentioning

confidence: 99%

mentioning

confidence: 99%

“COVID new normal” in ophthalmology: Implications for ophthalmologists, eye care, ophthalmic education and research

Mack

Fraser‐Bell

2021

Clinical Exper Ophthalmology

View full text Add to dashboard Cite

“…On the other hand, the viral infection can occur at the upper respiratory tract and viruses can migrate to the nasolacrimal duct and to the conjunctiva, resulting in viral conjunctivitis [62]. Furthermore, SARS-CoV-2 infection via the conjunctival tissues may also occur in non-human primates that the SARS-CoV-2 inoculation has been shown to cause mild COVID-19 in rhesus macaques [63].…”

Section: Potential Systemic Invasiveness Of Sars-cov-2 Following Ocular Transmissionmentioning

confidence: 99%

Potency of SARS-CoV-2 on Ocular Tissues

Durak¹,

Sutova²,

Yetisgin³

et al. 2021

Infectious Eye Diseases - Recent Advances in Diagnosis and Treatment

View full text Add to dashboard Cite

The current COVID-19 pandemic has affected more than 100 million people and resulted in morbidity and mortality around the world. Even though the disease caused by SARS-CoV-2 is characterized by respiratory tract involvement, previous and recent data also indicates ocular manifestation. Not surprisingly, cell entry point of the virus, ACE2 receptor, is widely expressed in ocular tissues ranging from conjunctiva to retina. Despite the sensibility of ocular tissues, the sophisticated defense mechanism of the eye might eliminate viral transmission. Nevertheless, the potential of systemic transmission through the nasolacrimal duct may not be eliminated. In the case of ocular involvement, the disease outcomes might be as treatable as conjunctivitis or as serious as retinal degeneration and the treatment regimen vary accordingly. Within these contingencies, our aim with this chapter is to shed light on molecular bases of SARS-CoV-2 infection, systemic invasiveness following ocular transmission, manifestation and permanent effects on ocular tissues.

show abstract

“…Many reports have underlined the specific risks of SARS-CoV-2 infection in ophthalmology [19][20][21][22][23][24][25][26][27][28]. The ophthalmic examination requires close, face-to face contact with patients, and the risk of viral shedding from the respiratory tract might represent a substantial issue for eye care practitioners [19,20,25,26,[28][29][30][31].…”

Section: Ophthalmology Practice and Infection Riskmentioning

confidence: 99%

Rethinking Elective Cataract Surgery Diagnostics, Assessments, and Tools after the COVID-19 Pandemic Experience and Beyond: Insights from the EUROCOVCAT Group

Tognetto

Brézin

Cummings³

et al. 2020

Diagnostics

View full text Add to dashboard Cite

The progressive deterioration of the visual function in patients on waiting lists for cataract surgery has a negative impact on their quality of life, especially in the elderly population. Patient waiting times for cataract surgeries in many healthcare settings have increased recently due to the prolonged stop or slowdown of elective cataract surgery as a result of coronavirus disease 19 (COVID-19). The aim of this review is to highlight the impact of such a “de-prioritization” of cataract surgery and to summarize some critical issues and useful hints on how to reorganize cataract pathways, with a special focus on perioperative diagnostic tools during the recovery phase and beyond. The experiences of a group of surgeons originating from nine different countries, named the European COVID-19 Cataract Group (EUROCOVCAT), have been combined with the literature and recommendations from scientific ophthalmic societies and healthcare institutions. Key considerations for elective cataract surgery should include the reduction of the number of unnecessary visits and examinations, adoption of precautionary measures, and implementation of telemedicine instruments. New strategies should be adopted to provide an adequate level of assistance and to guarantee safety conditions. Flexibility will be the watchword and regular updates would be necessary following scientific insights and the development of the pandemic.

show abstract

SARS‐CoV‐2 and COVID‐19 for the ophthalmologist

Cited by 9 publications

References 121 publications

“COVID new normal” in ophthalmology: Implications for ophthalmologists, eye care, ophthalmic education and research

“COVID new normal” in ophthalmology: Implications for ophthalmologists, eye care, ophthalmic education and research

Potency of SARS-CoV-2 on Ocular Tissues

Rethinking Elective Cataract Surgery Diagnostics, Assessments, and Tools after the COVID-19 Pandemic Experience and Beyond: Insights from the EUROCOVCAT Group

Contact Info

Product

Resources

About